Bright Minds Biosciences Inc. (DRUG) Ownership

$35.33

south_east
-$0.08 (-0.23%)
Day's range
$35.02
Day's range
$36.51

Bright Minds Biosciences Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ADVISORSHARES INVESTMENTS LLC 11/14/2024 182,420 $218,904   0.79% 4.09%
NATIONAL BANK OF CANADA /FI/ 11/15/2024 4,959 $5,802   -0.82% 0.11%
UBS GROUP AG 11/14/2024 3,407 $3,986   100.00% 0.08%
ASPIRE PRIVATE CAPITAL, LLC 10/25/2024 100 $117   0.00% 0.00%
BLACKROCK FUNDING, INC. /DE 11/13/2024 1 $1   100.00% 0.00%
JANE STREET GROUP, LLC 11/15/2024 0 $0   -100.00% 0.00%

Bright Minds Biosciences Inc.institutional Ownership - FAQ's

Who are the largest shareholders of DRUG shares?

During the previous two years, 6 institutional investors and hedge funds held shares of Bright Minds Biosciences Inc.. The most heavily invested institutionals were:

AdvisorShares Investments LLC: 182,420

NATIONAL BANK OF CANADA /FI/: 4,959

UBS Group AG: 3,407

Aspire Private Capital, LLC: 100

BlackRock Funding, Inc. /DE: 1

JANE STREET GROUP, LLC: 0

What percentage of Bright Minds Biosciences Inc. stock is owned by institutional investors?

4.29% of Bright Minds Biosciences Inc. stock is owned by institutional investors.

How much institutional buying is happening at DRUG ?

Institutional investors have bought a total of 190,887 shares in the last 24 months. This purchase volume represents approximately $6.74 M in transactions.